Binder Information
| Binder General Information | Top | |||
|---|---|---|---|---|
| Binder ID |
B1ZKU4
|
|||
| Binder Name |
Latanoprost
|
|||
| Synonyms |
Xalatan; PhXA41; PHXA-41; PhXA 41; UNII-6Z5B6HVF6O; Latanoprost, ethanol solution; 6Z5B6HVF6O; MFCD00216074; XA-41; T-2345; Catioprost; SMR000466354; Xalatan (TN); latanoprost (isopropyl ester); latanoprostum; Nova-21027; Latanoprost [USAN:INN:BAN]; XA 41; PhXA34 [as 15(R,S)-isomer]; AR-202; L-PPDS; Latanoprost, (+/-)-; CHEMBL1051; SCHEMBL24698; MLS000759468; MLS001424106; Latanoprost (JAN/USP/INN); GTPL1961; DTXSID1041057; HMS2051H11; HMS2089J17; HMS3715N22; EX-A1770; HY-B0577; ABP001061; BDBM50240648; s4709; ZINC12468792; Latanoprost, >=98% (HPLC), oil; AKOS024458331; AT-3016; CCG-100946; DB00654; NC00196; NCGC00246969-01; NCGC00246969-06; AS-75099; SC-18987; L0262; D00356; 33537-EP2295409A1; 33537-EP2311820A1; AB00640005-04; AB00640005-06; 209L824; A806039; Q634959; SR-01000759428; J-005764; SR-01000759428-4; UNII-8S5FB3XXG8 component GGXICVAJURFBLW-CEYXHVGTSA-N; Latanoprost, United States Pharmacopeia (USP) Reference Standard; Tris(2,4-dimethylphenyl)phosphine-5,5',5''''-trisulfonic acid trisodium salt
Click to Show/Hide
|
|||
| Binder Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C26H40O5
|
|||
| Canonical SMILES |
CC(C)OC(=O)CCC/C=C\\C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O
|
|||
| InChI |
1S/C26H40O5/c1-19(2)31-26(30)13-9-4-3-8-12-22-23(25(29)18-24(22)28)17-16-21(27)15-14-20-10-6-5-7-11-20/h3,5-8,10-11,19,21-25,27-29H,4,9,12-18H2,1-2H3/b8-3-/t21-,22+,23+,24-,25+/m0/s1
|
|||
| InChIKey |
GGXICVAJURFBLW-CEYXHVGTSA-N
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:6384
|
|||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.